260 related articles for article (PubMed ID: 25241249)
1. MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target.
Albarnaz JD; De Oliveira LC; Torres AA; Palhares RM; Casteluber MC; Rodrigues CM; Cardozo PL; De Souza AM; Pacca CC; Ferreira PC; Kroon EG; Nogueira ML; Bonjardim CA
Antiviral Res; 2014 Nov; 111():82-92. PubMed ID: 25241249
[TBL] [Abstract][Full Text] [Related]
2. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
[TBL] [Abstract][Full Text] [Related]
3. Thiosemicarbazones and Phthalyl-Thiazoles compounds exert antiviral activity against yellow fever virus and Saint Louis encephalitis virus.
Pacca CC; Marques RE; Espindola JWP; Filho GBOO; Leite ACL; Teixeira MM; Nogueira ML
Biomed Pharmacother; 2017 Mar; 87():381-387. PubMed ID: 28068627
[TBL] [Abstract][Full Text] [Related]
4. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection
Douam F; Soto Albrecht YE; Hrebikova G; Sadimin E; Davidson C; Kotenko SV; Ploss A
mBio; 2017 Aug; 8(4):. PubMed ID: 28811340
[TBL] [Abstract][Full Text] [Related]
5. Establishment of Vero cell lines persistently harboring a yellow fever virus 17D subgenomic replicon.
Saito K; Shimasaki K; Fukasawa M; Suzuki R; Okemoto-Nakamura Y; Katoh K; Takasaki T; Hanada K
Virus Res; 2022 Dec; 322():198935. PubMed ID: 36152929
[TBL] [Abstract][Full Text] [Related]
6. New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.
Fernandes-Monteiro AG; Trindade GF; Yamamura AM; Moreira OC; de Paula VS; Duarte AC; Britto C; Lima SM
Hum Vaccin Immunother; 2015; 11(7):1865-71. PubMed ID: 26011746
[TBL] [Abstract][Full Text] [Related]
7. Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection.
Lefeuvre A; Contamin H; Decelle T; Fournier C; Lang J; Deubel V; Marianneau P
Microbes Infect; 2006 May; 8(6):1530-8. PubMed ID: 16697681
[TBL] [Abstract][Full Text] [Related]
8. Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo.
de Freitas CS; Higa LM; Sacramento CQ; Ferreira AC; Reis PA; Delvecchio R; Monteiro FL; Barbosa-Lima G; James Westgarth H; Vieira YR; Mattos M; Rocha N; Hoelz LVB; Leme RPP; Bastos MM; Rodrigues GOL; Lopes CEM; Queiroz-Junior CM; Lima CX; Costa VV; Teixeira MM; Bozza FA; Bozza PT; Boechat N; Tanuri A; Souza TML
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007072. PubMed ID: 30699122
[TBL] [Abstract][Full Text] [Related]
9. RNA interference inhibits yellow fever virus replication in vitro and in vivo.
Pacca CC; Severino AA; Mondini A; Rahal P; D'avila SG; Cordeiro JA; Nogueira MC; Bronzoni RV; Nogueira ML
Virus Genes; 2009 Apr; 38(2):224-31. PubMed ID: 19169857
[TBL] [Abstract][Full Text] [Related]
10. The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication.
Andrade AA; Silva PN; Pereira AC; De Sousa LP; Ferreira PC; Gazzinelli RT; Kroon EG; Ropert C; Bonjardim CA
Biochem J; 2004 Jul; 381(Pt 2):437-46. PubMed ID: 15025565
[TBL] [Abstract][Full Text] [Related]
11. Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.
Liang H; Lee M; Jin X
Cell Mol Immunol; 2016 Jan; 13(1):36-46. PubMed ID: 26435066
[TBL] [Abstract][Full Text] [Related]
12. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.
Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD
Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778
[TBL] [Abstract][Full Text] [Related]
13. Wild terrestrial rainforest mammals as potential reservoirs for flaviviruses (yellow fever, dengue 2 and St Louis encephalitis viruses) in French Guiana.
de Thoisy B; Dussart P; Kazanji M
Trans R Soc Trop Med Hyg; 2004 Jul; 98(7):409-12. PubMed ID: 15138077
[TBL] [Abstract][Full Text] [Related]
14. Porcine reproductive and respiratory syndrome virus replication is suppressed by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.
Lee YJ; Lee C
Virus Res; 2010 Sep; 152(1-2):50-8. PubMed ID: 20540975
[TBL] [Abstract][Full Text] [Related]
15. Limited evolution of the yellow fever virus 17d in a mouse infection model.
Kum DB; Mishra N; Vrancken B; Thibaut HJ; Wilder-Smith A; Lemey P; Neyts J; Dallmeier K
Emerg Microbes Infect; 2019; 8(1):1734-1746. PubMed ID: 31797751
[TBL] [Abstract][Full Text] [Related]
16. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b.
Putnak JR; Schlesinger JJ
J Gen Virol; 1990 Aug; 71 ( Pt 8)():1697-702. PubMed ID: 2144016
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].
Ergünay K; Saygan MB; Aydoğan S; Litzba N; Niedrig M; Pınar A; Us D
Mikrobiyol Bul; 2010 Jul; 44(3):415-24. PubMed ID: 21063991
[TBL] [Abstract][Full Text] [Related]
18. Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections.
Neyts J; Meerbach A; McKenna P; De Clercq E
Antiviral Res; 1996 May; 30(2-3):125-32. PubMed ID: 8783804
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model.
Engelmann F; Josset L; Girke T; Park B; Barron A; Dewane J; Hammarlund E; Lewis A; Axthelm MK; Slifka MK; Messaoudi I
PLoS Negl Trop Dis; 2014; 8(11):e3295. PubMed ID: 25412185
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
